Single-institution outcome experience using AlloDerm® as temporary coverage or definitive reconstruction for cutaneous and soft tissue malignancy defects

Jeremiah Deneve, Kiran K. Turaga, Suroosh S. Marzban, Christopher A. Puleo, Amod A. Sarnaik, Ricardo J. Gonzalez, Vernon K. Sondak, Jonathan S. Zager

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Definitive reconstruction after excision of cutaneous and soft tissue malignancies is sometimes limited as a result of lack of native tissue coverage options, patient comorbidities, or pending permanent margin analysis. Acellular dermis (AlloDerm®) reconstruction offers an excellent coverage alternative in these situations. We describe our experience using AlloDerm for coverage of skin and soft tissue defects. An Institutional Review Board approved review of patients undergoing skin/soft tissue coverage with AlloDerm from 2006 to 2012 was performed. Clinicopathologic variables, early postoperative findings, and subjective final cosmetic outcome were analyzed. Sixty-seven patients underwent AlloDerm reconstruction. Melanoma (67%) was the most frequent diagnosis. The median defect size was 42 cm 2 (range, 2 to 340 cm 2 ), involving predominantly the lower extremity (45%) or head and neck (32%). AlloDerm was intended for use as a temporary dressing in 64 per cent (43 of 67) and permanent coverage in 24 (36%). Ten patients required reexcision for positive margins. Twenty-five (37%) underwent split-thickness skin graft or flap coverage after AlloDerm placement. Radiation was administered to 16 patients (24%) after AlloDerm reconstruction within a median of 53 days after surgery (range, 18 to 118 days). At first postoperative examination (median, 11 days after surgery), 85 per cent had evidence of healthy AlloDerm incorporation. Cellulitis was the most frequent complication (13%), all resolving with oral antibiotics. AlloDerm reconstruction after skin and soft tissue resection offers a suitable coverage alternative and may serve as a bridge to permanent reconstruction or as a permanent biologic dressing of complex surgical defects. In situations in which adjuvant radiation is needed, AlloDerm can be used without major complications. Copyright Southeastern Surgical Congress. All rights reserved.

Original languageEnglish (US)
Pages (from-to)476-482
Number of pages7
JournalAmerican Surgeon
Volume79
Issue number5
StatePublished - May 1 2013
Externally publishedYes

Fingerprint

Skin
Neoplasms
Ambulatory Surgical Procedures
Biological Dressings
Acellular Dermis
Alloderm
Radiation
Cellulitis
Research Ethics Committees
Bandages
Cosmetics
Comorbidity
Lower Extremity
Melanoma
Neck
Head
Anti-Bacterial Agents
Transplants

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Deneve, J., Turaga, K. K., Marzban, S. S., Puleo, C. A., Sarnaik, A. A., Gonzalez, R. J., ... Zager, J. S. (2013). Single-institution outcome experience using AlloDerm® as temporary coverage or definitive reconstruction for cutaneous and soft tissue malignancy defects. American Surgeon, 79(5), 476-482.

Single-institution outcome experience using AlloDerm® as temporary coverage or definitive reconstruction for cutaneous and soft tissue malignancy defects. / Deneve, Jeremiah; Turaga, Kiran K.; Marzban, Suroosh S.; Puleo, Christopher A.; Sarnaik, Amod A.; Gonzalez, Ricardo J.; Sondak, Vernon K.; Zager, Jonathan S.

In: American Surgeon, Vol. 79, No. 5, 01.05.2013, p. 476-482.

Research output: Contribution to journalArticle

Deneve, J, Turaga, KK, Marzban, SS, Puleo, CA, Sarnaik, AA, Gonzalez, RJ, Sondak, VK & Zager, JS 2013, 'Single-institution outcome experience using AlloDerm® as temporary coverage or definitive reconstruction for cutaneous and soft tissue malignancy defects', American Surgeon, vol. 79, no. 5, pp. 476-482.
Deneve, Jeremiah ; Turaga, Kiran K. ; Marzban, Suroosh S. ; Puleo, Christopher A. ; Sarnaik, Amod A. ; Gonzalez, Ricardo J. ; Sondak, Vernon K. ; Zager, Jonathan S. / Single-institution outcome experience using AlloDerm® as temporary coverage or definitive reconstruction for cutaneous and soft tissue malignancy defects. In: American Surgeon. 2013 ; Vol. 79, No. 5. pp. 476-482.
@article{cfd68080568d459cb57e0e4d195f55bc,
title = "Single-institution outcome experience using AlloDerm{\circledR} as temporary coverage or definitive reconstruction for cutaneous and soft tissue malignancy defects",
abstract = "Definitive reconstruction after excision of cutaneous and soft tissue malignancies is sometimes limited as a result of lack of native tissue coverage options, patient comorbidities, or pending permanent margin analysis. Acellular dermis (AlloDerm{\circledR}) reconstruction offers an excellent coverage alternative in these situations. We describe our experience using AlloDerm for coverage of skin and soft tissue defects. An Institutional Review Board approved review of patients undergoing skin/soft tissue coverage with AlloDerm from 2006 to 2012 was performed. Clinicopathologic variables, early postoperative findings, and subjective final cosmetic outcome were analyzed. Sixty-seven patients underwent AlloDerm reconstruction. Melanoma (67{\%}) was the most frequent diagnosis. The median defect size was 42 cm 2 (range, 2 to 340 cm 2 ), involving predominantly the lower extremity (45{\%}) or head and neck (32{\%}). AlloDerm was intended for use as a temporary dressing in 64 per cent (43 of 67) and permanent coverage in 24 (36{\%}). Ten patients required reexcision for positive margins. Twenty-five (37{\%}) underwent split-thickness skin graft or flap coverage after AlloDerm placement. Radiation was administered to 16 patients (24{\%}) after AlloDerm reconstruction within a median of 53 days after surgery (range, 18 to 118 days). At first postoperative examination (median, 11 days after surgery), 85 per cent had evidence of healthy AlloDerm incorporation. Cellulitis was the most frequent complication (13{\%}), all resolving with oral antibiotics. AlloDerm reconstruction after skin and soft tissue resection offers a suitable coverage alternative and may serve as a bridge to permanent reconstruction or as a permanent biologic dressing of complex surgical defects. In situations in which adjuvant radiation is needed, AlloDerm can be used without major complications. Copyright Southeastern Surgical Congress. All rights reserved.",
author = "Jeremiah Deneve and Turaga, {Kiran K.} and Marzban, {Suroosh S.} and Puleo, {Christopher A.} and Sarnaik, {Amod A.} and Gonzalez, {Ricardo J.} and Sondak, {Vernon K.} and Zager, {Jonathan S.}",
year = "2013",
month = "5",
day = "1",
language = "English (US)",
volume = "79",
pages = "476--482",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "5",

}

TY - JOUR

T1 - Single-institution outcome experience using AlloDerm® as temporary coverage or definitive reconstruction for cutaneous and soft tissue malignancy defects

AU - Deneve, Jeremiah

AU - Turaga, Kiran K.

AU - Marzban, Suroosh S.

AU - Puleo, Christopher A.

AU - Sarnaik, Amod A.

AU - Gonzalez, Ricardo J.

AU - Sondak, Vernon K.

AU - Zager, Jonathan S.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Definitive reconstruction after excision of cutaneous and soft tissue malignancies is sometimes limited as a result of lack of native tissue coverage options, patient comorbidities, or pending permanent margin analysis. Acellular dermis (AlloDerm®) reconstruction offers an excellent coverage alternative in these situations. We describe our experience using AlloDerm for coverage of skin and soft tissue defects. An Institutional Review Board approved review of patients undergoing skin/soft tissue coverage with AlloDerm from 2006 to 2012 was performed. Clinicopathologic variables, early postoperative findings, and subjective final cosmetic outcome were analyzed. Sixty-seven patients underwent AlloDerm reconstruction. Melanoma (67%) was the most frequent diagnosis. The median defect size was 42 cm 2 (range, 2 to 340 cm 2 ), involving predominantly the lower extremity (45%) or head and neck (32%). AlloDerm was intended for use as a temporary dressing in 64 per cent (43 of 67) and permanent coverage in 24 (36%). Ten patients required reexcision for positive margins. Twenty-five (37%) underwent split-thickness skin graft or flap coverage after AlloDerm placement. Radiation was administered to 16 patients (24%) after AlloDerm reconstruction within a median of 53 days after surgery (range, 18 to 118 days). At first postoperative examination (median, 11 days after surgery), 85 per cent had evidence of healthy AlloDerm incorporation. Cellulitis was the most frequent complication (13%), all resolving with oral antibiotics. AlloDerm reconstruction after skin and soft tissue resection offers a suitable coverage alternative and may serve as a bridge to permanent reconstruction or as a permanent biologic dressing of complex surgical defects. In situations in which adjuvant radiation is needed, AlloDerm can be used without major complications. Copyright Southeastern Surgical Congress. All rights reserved.

AB - Definitive reconstruction after excision of cutaneous and soft tissue malignancies is sometimes limited as a result of lack of native tissue coverage options, patient comorbidities, or pending permanent margin analysis. Acellular dermis (AlloDerm®) reconstruction offers an excellent coverage alternative in these situations. We describe our experience using AlloDerm for coverage of skin and soft tissue defects. An Institutional Review Board approved review of patients undergoing skin/soft tissue coverage with AlloDerm from 2006 to 2012 was performed. Clinicopathologic variables, early postoperative findings, and subjective final cosmetic outcome were analyzed. Sixty-seven patients underwent AlloDerm reconstruction. Melanoma (67%) was the most frequent diagnosis. The median defect size was 42 cm 2 (range, 2 to 340 cm 2 ), involving predominantly the lower extremity (45%) or head and neck (32%). AlloDerm was intended for use as a temporary dressing in 64 per cent (43 of 67) and permanent coverage in 24 (36%). Ten patients required reexcision for positive margins. Twenty-five (37%) underwent split-thickness skin graft or flap coverage after AlloDerm placement. Radiation was administered to 16 patients (24%) after AlloDerm reconstruction within a median of 53 days after surgery (range, 18 to 118 days). At first postoperative examination (median, 11 days after surgery), 85 per cent had evidence of healthy AlloDerm incorporation. Cellulitis was the most frequent complication (13%), all resolving with oral antibiotics. AlloDerm reconstruction after skin and soft tissue resection offers a suitable coverage alternative and may serve as a bridge to permanent reconstruction or as a permanent biologic dressing of complex surgical defects. In situations in which adjuvant radiation is needed, AlloDerm can be used without major complications. Copyright Southeastern Surgical Congress. All rights reserved.

UR - http://www.scopus.com/inward/record.url?scp=84877801850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877801850&partnerID=8YFLogxK

M3 - Article

VL - 79

SP - 476

EP - 482

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 5

ER -